Localization of calcium-binding proteins and GABA transporter (GAT-1) messenger RNA in the human subthalamic nucleus

被引:34
作者
Augood, SJ
Waldvogel, HJ
Münkle, MC
Faull, RLM
Emson, PC
机构
[1] Babraham Inst, Dept Neurobiol, Cambridge CB2 4AT, England
[2] Univ Auckland, Fac Med & Hlth Sci, Dept Anat Radiol, Auckland 1, New Zealand
基金
英国惠康基金;
关键词
Parkinson's disease; neurodegenerative disease; basal ganglia; parvalbumin; calbindin; calretinin;
D O I
10.1016/S0306-4522(98)00226-7
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The distribution of messenger RNA encoding the human GAT-1 (a high-affinity GABA transporter) was investigated in the subthalamic nucleus of 10 neurologically normal human post mortem cases. Further, the distribution of messenger RNA and protein encoding the three neuronally expressed calcium-binding proteins (calbindin D28k, parvalbumin and calretinin) was similarly investigated using in situ hybridization and immunohistochemical techniques. Cellular sites of calbindin D28k, parvalbumin, calretinin and GAT-1 messenger RNA expression were localized using human-specific oligonucleotide probes radiolabelled with [S-35]dATP. Sites of protein localization were visualized using specific anti-calbindin D28k, anti-parvalbumin and anti-calretinin antisera. Examination of emulsion-coated tissue sections processed for in situ hybridization revealed an intense signal for GAT-1 messenger RNA within the human subthalamic nucleus, indeed the majority of Methylene Blue-counterstained cells were enriched in this transcript. Further, a marked heterogeneity was noted with regard to the expression of the messenger RNA's encoding the three calcium-binding proteins; this elliptical nucleus was highly enriched in parvalbumin messenger RNA-positive neurons and calretinin mRNA-positive cells but not calbindin messenger RNA-positive cells. Indeed, only an occasional calbindin messenger RNA-positive cell was detected within the mediolateral extent of the nucleus. In marked contrast, numerous parvalbumin messenger RNA-positive cells and calretinin messenger RNA-positive cells were detected and they were topographically distributed; parvalbumin messenger RNA-positive cells were highly enriched in the dorsal subthalamic nucleus extending mediolaterally; calretinin messenger RNA-positive cells were more enriched ventrally although some degree of overlap was apparent. Computer-assisted analysis of the average cross-sectional somatic area of parvalbumin, calretinin and GAT-I messenger RNA-positive neurons revealed them all to be in the range of 300 mu m(2). The unique patterns of calcium-binding protein gene expression were similarly reflected at the protein level; an abundance of parvalbumin- and calretinin-immunopositive neurons were observed whereas only occasional intensely-labelled calbindin-immunopositive fibres were seen, no calbindin-immunopositive cells were detected. Single and double labelling studies show that parvalbumin-immunopositive neurons were mainly localized in the dorsal region of the nucleus, and calretinin-immunopositive neurons were mainly localized in the ventral region although there was overlap with double-labelled neurons located in the middle and dorsal regions. The significance of these findings, in particular the expression of GAT-1, a high-affinity GABA uptake protein, for basal ganglia signalling is discussed. (C) 1998 IBRO. Published by Elsevier Science Ltd.
引用
收藏
页码:521 / 534
页数:14
相关论文
共 48 条
[1]   THE FUNCTIONAL-ANATOMY OF BASAL GANGLIA DISORDERS [J].
ALBIN, RL ;
YOUNG, AB ;
PENNEY, JB .
TRENDS IN NEUROSCIENCES, 1989, 12 (10) :366-375
[2]   FELINE SUBTHALAMIC NUCLEUS NEURONS CONTAIN GLUTAMATE-LIKE BUT NOT GABA-LIKE OR GLYCINE-LIKE IMMUNOREACTIVITY [J].
ALBIN, RL ;
ALDRIDGE, JW ;
YOUNG, AB ;
GILMAN, S .
BRAIN RESEARCH, 1989, 491 (01) :185-188
[3]  
AMALRIC M, 1995, BEHAV PHARMACOL, V6, P508
[4]   Reduction in enkephalin and substance P messenger RNA in the striatum of early grade Huntington's disease: A detailed cellular in situ hybridization study [J].
Augood, SJ ;
Faull, RLM ;
Love, DR ;
Emson, PC .
NEUROSCIENCE, 1996, 72 (04) :1023-1036
[5]  
AUGOOD SJ, 1995, J NEUROSCI, V15, P865
[6]  
BAUNEZ C, 1995, J NEUROSCI, V15, P6531
[7]   REVERSAL OF RIGIDITY AND IMPROVEMENT IN MOTOR-PERFORMANCE BY SUBTHALAMIC HIGH-FREQUENCY STIMULATION IN MPTP-TREATED MONKEYS [J].
BENAZZOUZ, A ;
GROSS, C ;
FEGER, J ;
BORAUD, T ;
BIOULAC, B .
EUROPEAN JOURNAL OF NEUROSCIENCE, 1993, 5 (04) :382-389
[8]   REVERSAL OF EXPERIMENTAL PARKINSONISM BY LESIONS OF THE SUBTHALAMIC NUCLEUS [J].
BERGMAN, H ;
WICHMANN, T ;
DELONG, MR .
SCIENCE, 1990, 249 (4975) :1436-1438
[9]  
BORDEN LA, 1995, J NEUROCHEM, V64, P977
[10]   PARVALBUMIN-D28K-IMMUNOREACTIVITY, CALRETININ-D28K-IMMUNOREACTIVITY AND CALBINDIN-D28K-IMMUNOREACTIVITY AND GABA IN A FOREBRAIN REGION INVOLVED IN AUDITORY FILIAL IMPRINTING [J].
BRAUN, K ;
SCHEICH, H ;
BRAUN, S ;
ROGERS, JH ;
HEIZMANN, CW .
BRAIN RESEARCH, 1991, 539 (01) :31-44